Literature DB >> 9046761

Inadequate hepatitis B vaccination of adolescents and adults at an urban community health center.

J Sharfstein1, P H Wise.   

Abstract

Hepatitis B remains a major public health problem in the United States, but public vaccination policy has targeted infants rather than the high-risk adults who constitute the vast majority of patients at imminent risk of infection. The effects of this policy were studied at a community health center in Boston. Adolescents and adults who attended a community health center between January 1, 1992 and May 31, 1993 and had human immunodeficiency virus (HIV) or another sexually transmitted disease (STD)--indications for vaccination according to the Centers for Disease Control and Prevention--were identified through chart review. The vaccination rate and missed opportunities were determined. In addition, directors of Boston health centers were surveyed on hepatitis B vaccine at their clinics. Of 178 individuals with HIV or another STD and without serologic evidence of prior exposure to hepatitis B, two (1.1%) received the vaccine. There were 342 missed opportunities. Only two of 14 medical directors said their clinics routinely offered vaccine to individuals with STDs. The medical directors rated financial barriers as more important obstacles to hepatitis B vaccination than nonfinancial barriers. These results indicate that many high-risk adolescents and adults do not receive a preventive intervention that is federally recommended, potentially life saving, and cost effective. Inadequate public funding for vaccine may be a key barrier for this population.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9046761      PMCID: PMC2608223     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  6 in total

1.  Universal neonatal hepatitis B immunization--are we jumping on the bandwagon too early?

Authors:  T G Ganiats; M T Bowersox; L P Ralph
Journal:  J Fam Pract       Date:  1993-02       Impact factor: 0.493

Review 2.  Immunization of adults.

Authors:  P Gardner; W Schaffner
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245

3.  Universal hepatitis B immunization of infants: reactions of pediatricians and family physicians over time.

Authors:  G L Freed; W C Bordley; S J Clark; T R Konrad
Journal:  Pediatrics       Date:  1994-05       Impact factor: 7.124

4.  The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies.

Authors:  M J Alter; S C Hadler; H S Margolis; W J Alexander; P Y Hu; F N Judson; A Mares; J K Miller; L A Moyer
Journal:  JAMA       Date:  1990-03-02       Impact factor: 56.272

Review 5.  Hepatitis B: evolving epidemiology and implications for control.

Authors:  H S Margolis; M J Alter; S C Hadler
Journal:  Semin Liver Dis       Date:  1991-05       Impact factor: 6.115

6.  Failure to deliver hepatitis B vaccine: confessions from a genitourinary medicine clinic.

Authors:  N Bhatti; R J Gilson; M Beecham; P Williams; M P Matthews; R S Tedder; I V Weller
Journal:  BMJ       Date:  1991-07-13
  6 in total
  4 in total

Review 1.  Understanding correlates of hepatitis B virus vaccination in men who have sex with men: what have we learned?

Authors:  L J Yee; S D Rhodes
Journal:  Sex Transm Infect       Date:  2002-10       Impact factor: 3.519

2.  Impact of antiretroviral protocols on dynamics of AIDS progression markers.

Authors:  S Resino; J M Bellón; S Sánchez-Ramón; D Gurbindo; J Ruiz-Contreras; J A León; J T Ramos; M A Muñóz-Fernández
Journal:  Arch Dis Child       Date:  2002-02       Impact factor: 3.791

3.  Risk of hepatitis B infection among young injection drug users in San Francisco: opportunities for intervention.

Authors:  K H Seal; K C Ochoa; J A Hahn; J P Tulsky; B R Edlin; A R Moss
Journal:  West J Med       Date:  2000-01

4.  A community-based study of hepatitis B infection and immunization among young adults in a high-drug-use neighborhood in New York City.

Authors:  Benny J Kottiri; Samuel R Friedman; Gary L Euler; Peter L Flom; Milagros Sandoval; Alan Neaigus; Don C Des Jarlais; Jonathan M Zenilman
Journal:  J Urban Health       Date:  2005-07-20       Impact factor: 3.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.